Share this article
Share this article
NEW YORK, April 14, 2021 /PRNewswire/ -- PRECISIONvalue, a Precision Value & Health team, today announced the further strategic expansion of its Access Experience Team (AET), a specialized group of former access decision markers, with the addition of Christy Banach. Christy's deep oncology practice background bolsters Precison's ability to futher drive strategic and implementation support related to real-time experiences being managed at the point of patient care within oncology practices.
To address the dynamic market access landscape, Precision has assembled the AET, an industry-leading group of 25+ former market access decision makers. As day-to-day leaders in access decision-making roles, AET members have an intimate understanding of the evolving drug marketplace and strong ties to their current industry. From this nuanced understanding of how market access stakeholders measure value and the supporting evidence, the AET works across Precision Value & Health to help dozens of clients secure desired levels of market access for their medical innovations.